Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)
NCT ID: NCT05758883
Last Updated: 2024-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
196 participants
OBSERVATIONAL
2023-01-12
2024-02-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IC-8 Apthera IOL New Enrollment Post Approval Study
NCT06060041
Evaluation of Long-Term Clinical Acceptability and Satisfaction With the IC-8 Intraocular Lens
NCT03314766
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
NCT03633695
Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs
NCT03733730
IOL Implantation After KAMRA Inlay Removal
NCT03320473
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IC-8 Apthera intraocular lens (IOL) Group
Patients previously enrolled in the IC-8 Apthera IOL Investigational Device Exemption (IDE) study (G180075) and implanted with the IC-8 Apthera IOL.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to comprehend and have signed a statement of informed consent
* Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visit(s)
22 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AcuFocus, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fishkind, Bakewell, Maltzman, Hunter & Associates Eye Care & Surgery Center
Tucson, Arizona, United States
Empire Eye & Laser Center
Bakersfield, California, United States
Harvard Eye Associates
Laguna Hills, California, United States
Altos Eye Physicians
Los Altos, California, United States
Advanced Vision Care
Los Angeles, California, United States
Eye Center of Northern Colorado
Fort Collins, Colorado, United States
Chu Vision Institute
Bloomington, Minnesota, United States
Pepose Vision Institute
St Louis, Missouri, United States
Kugler Vision
Omaha, Nebraska, United States
Alterman, Modi & Wolter
Poughkeepsie, New York, United States
Physicians Protocol
Greensboro, North Carolina, United States
Cleveland Eye Clinic
Brecksville, Ohio, United States
Philadelphia Eye Associates
Philadelphia, Pennsylvania, United States
Bucci Laser Vision
Wilkes-Barre, Pennsylvania, United States
Vance Thompson Vision
Sioux Falls, South Dakota, United States
Baylor College of Medicine
Houston, Texas, United States
Parkhurst NuVision
San Antonio, Texas, United States
Hoopes Vision
Draper, Utah, United States
Utah Eye Centers
Ogden, Utah, United States
Virginia Eye Consultants
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAIL-101-PAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.